Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Amgen Doubles Down On AI, Genomic Investments In R&D
New Tech, R&D Heads ‘Joined At The Hip’
Jan 26 2024
•
By
Mandy Jackson
Amgen is using artificial intelligence to search genomic data for new drug targets, among other uses • Source: Shutterstock
More from AI
More from Digital Technologies